a
a
Weather:
No weather information available
HomeHealthInfinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial

Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial

Infinitopes’ lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, “off-the-shelf” cancer vaccine, designed to save lives by preventing disease recurrence in first-line patients with surgically resectable cancers Infinitopes’ proprietary vector delivery…

No comments

Sorry, the comment form is closed at this time.

Translate »